To the editor

Nature Medicine

Volumn 17, Issue 9, 2011, Pages 1040-1041

  Dansette, Patrick M ^a   Rosi, Julien ^a   Bertho, Gildas ^a   Mansuy, Daniel ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO CLOPIDOGREL; ARYLDIALKYLPHOSPHATASE 1; CLOPIDOGREL; CYTOCHROME P450; DRUG METABOLITE; UNCLASSIFIED DRUG;

DNA POLYMORPHISM; DRUG ACTIVATION; DRUG BLOOD LEVEL; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LOSS OF FUNCTION MUTATION; PRIORITY JOURNAL;

EID: 80052497112     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2436     Document Type: Letter

References (10)

1. Pereillo, J.M. et al. Drug Metab. Dispos. 30, 1288-1295 (2002).
2. Dansette, P.M., Libraire, J., Bertho, G. & Mansuy, D. Chem. Res. Toxicol. 22, 369-373 (2009).
3. Kazui, M. et al. Drug Metab. Dispos. 38, 92-99 (2010).
4. Sibbing, D. et al. Eur. Heart J. 32, 1605-1613 (2011).
5. Bouman, H.J. et al. Nat. Med. 17, 110-116 (2011).
6. Tuffal, G. et al. Thromb. Haemost. 105, 696-705 (2011).
7. Takahashi, M., Pang, H., Kawabata, K., Farid, N.A. & Kurihara, A. J. Pharm. Biomed. Anal. 48, 1219-1224 (2008).
8. Billecke, S. et al. Drug Metab. Dispos. 28, 1335-1342 (2000).
9. Correia, M.A. & Ortiz de Montellano, P.R. in Cytochrome P450 Structure, Mechanism, and Biochemistry 3rd edn. (ed. Ortiz de Montellano, P.R.) 247-295 (Kluwer Academic/Plenum Publishers, New York, 2005).
10. Mansuy, D. & Dansette, P.M. Arch. Biochem. Biophys. 507, 174-185 (2011).